Navigation Links
Genomic Health to Present at Canaccord Adams 29th Annual Global Growth Conference
Date:8/6/2009

REDWOOD CITY, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's Chief Executive Officer, will present at the Canaccord Adams 29th Annual Global Growth Conference in Boston, on Thursday, August 13 at 1:30 p.m. ET.

To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of Genomic Health's website athttp://investor.genomichealth.com. Please connect to the website at least 15 minutes prior to the beginning of the presentation to allow for any necessary software downloads. An archived replay will be available for three months beginning 24 hours after the live presentation.

About Genomic Health

Genomic Health, Inc. (Nasdaq: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched the Oncotype DX breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. In addition to the widely adopted Oncotype DX breast cancer test, Genomic Health is preparing to launch its Oncotype DX colon cancer test in early 2010. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.


'/>"/>
SOURCE Genomic Health
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Microarray provides 3 genomic guides to breast cancer treatment decisions
3. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
4. Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference
5. Genomic profiling of lung tumors helps doctors choose most effective treatment
6. Genomic technologies to identify toxic chemicals should be developed
7. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
8. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Genomic Health to Present at JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... 10, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... other healthcare organizations to promote diabetes education at the World Diabetes Day observance. ... of speakers from around the Commonwealth of Pennsylvania. Speakers included Dr. Renu ...
(Date:12/9/2016)... ... December 09, 2016 , ... The American ... audiologists—to remain a critical part of public access to hearing aid technology. , ... announced this week that, starting immediately, it would no longer enforce the ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... folded, pharmaceutical inserts and outserts. As a means of expanding capabilities Flottman ... will enable Flottman to individually code professional inserts (PIs) and patient package inserts ...
(Date:12/9/2016)... Woodland Hills, CA (PRWEB) , ... December 09, ... ... center for young adults, celebrated its 10th anniversary with the grand opening of ... Hills, California. The successful event spanned two days, December 2-3, and was attended ...
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Hotel in New York, NY, on December 3rd, to benefit Holy Name Medical ... the annual event, which raised over $1 million - the largest event in ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... DIEGO , Dec. 9, 2016 aTyr Pharma, Inc. ... discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, ... at the upcoming BMO Prescriptions for Success Healthcare Conference at the ... on Wednesday, December 14, 2016, at 4:20 p.m. ET. ... ...
(Date:12/9/2016)... Department of Health Secretary Dr. Karen ... dispensaries under Act 16 are slated for publication in ... now available online . "The dispensary temporary ... operation; process for dispensing medical marijuana; security and surveillance ... dispensary facilities can be located," said Secretary Murphy. "Our ...
(Date:12/8/2016)... Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... issued shares of common stock, $0.01 par value (the "Offering" ... public offering.  The final terms of the Offering will depend ... and there can be no assurance as to whether or ... to use the net proceeds it will receive from this ...
Breaking Medicine Technology: